Cystic Fibrosis Medicine to be Made Available to Island Children

Young children on the island living with cystic fibrosis will soon have access to a new medicine.

Kaftrio is a medicine used to treat patients with cystic fibrosis, an inherited disease that has severe effects on the lungs, the digestive system and other organs.

Today, the Cystic Fibrosis Trust said: ‘Following a letter from our Chief Executive David Ramsden asking that children aged 6-11 in the Isle of Man, Guernsey and Jersey have access to #Kaftrio, the Governments in the Crown Dependencies have confirmed that the treatment will now be available to those who are eligible.’

Earlier this year, the NHS said children would benefit from what it called a ‘miracle’ treatment. It said: ‘Nine out of 10 patients with cystic fibrosis – more than 7,000 people in England – can benefit from the ‘triple therapy’, which tackles the underlying causes of the disease as well as symptoms.

‘The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has now confirmed an extension to the licence for Kaftrio, which means more than 1,300 children in England with cystic fibrosis, aged six to 11, are newly eligible for this treatment.’

Leave a Reply

Your email address will not be published.